Novel interaction between Alzheimer’s disease-related protein presenilin 1 and glutamate transporter 1
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Novel interaction between Alzheimer’s disease-related protein presenilin 1 and glutamate transporter 1 ; volume:8 ; number:1 ; day:7 ; month:6 ; year:2018 ; pages:1-9 ; date:12.2018
Scientific reports ; 8, Heft 1 (7.6.2018), 1-9, 12.2018
- Creator
- Contributor
-
Maesako, Masato
Meier, Joshua
Berezovska, Oksana
SpringerLink (Online service)
- DOI
-
10.1038/s41598-018-26888-2
- URN
-
urn:nbn:de:101:1-2018080923374837236413
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zoltowska, Katarzyna Marta
- Maesako, Masato
- Meier, Joshua
- Berezovska, Oksana
- SpringerLink (Online service)
Other Objects (12)
Function and dysfunction of presenilin in Alzheimer’s disease
Identifying Alzheimer’s disease-related proteins by LRRGD
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations
Alzheimer’s disease-related transcriptional sex differences in myeloid cells
Presenilin E318G variant and Alzheimer’s disease risk: the Cache County study
Zinc transporters in Alzheimer’s disease
Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer’s disease
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
Cerebrospinal fluid Presenilin-1 increases at asymptomatic stage in genetically determined Alzheimer’s disease
Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer’s disease-related dysregulation
Function and dysfunction of presenilin in Alzheimer’s disease
Identifying Alzheimer’s disease-related proteins by LRRGD
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations
Alzheimer’s disease-related transcriptional sex differences in myeloid cells
Presenilin E318G variant and Alzheimer’s disease risk: the Cache County study
Zinc transporters in Alzheimer’s disease
Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer’s disease
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
Cerebrospinal fluid Presenilin-1 increases at asymptomatic stage in genetically determined Alzheimer’s disease
Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer’s disease-related dysregulation
Function and dysfunction of presenilin in Alzheimer’s disease
Identifying Alzheimer’s disease-related proteins by LRRGD
CSF Presenilin-1 complexes are increased in Alzheimer’s disease
Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations
Alzheimer’s disease-related transcriptional sex differences in myeloid cells
Presenilin E318G variant and Alzheimer’s disease risk: the Cache County study
Zinc transporters in Alzheimer’s disease
Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer’s disease
Identification and validation of Alzheimer’s disease-related metabolic brain pattern in biomarker confirmed Alzheimer’s dementia patients
Cerebrospinal fluid Presenilin-1 increases at asymptomatic stage in genetically determined Alzheimer’s disease